Home : DrugWatch : Xeloda : News Articles

Xeloda - News Articles

Merck Serono completes enrolment for Erbitux gastric cancer trial


Erbitux in combination with cisplatin and capecitabine chemotherapies as a potential first-line therapy for advanced/metastatic gastric adenocarcinoma. It is a multi-centre, open label, randomised and controlled study that will take place at 185 sites in 25 ...
NCI Cancer Bulletin for January 11, 2011 - National Cancer Institute


Phase III Study of Carboplatin and Paclitaxel with Versus without Bevacizumab Compared to Oxaliplatin and Capecitabine with Versus without Bevacizumab as First-Line Therapy in Patients with Newly Diagnosed Stage II-IV or Recurrent Stage I Mucinous Epithelial Ovarian or Fallopian Tube ...
Arch Dermatol -- Sign In Page


Capecitabine, a prodrug of fluorouracil, is a pyrimidine analogue that can inflame actinic keratoses. 1 The inflammation manifests primarily as simple ...
Vivir con metástasis de cáncer de mama no es color de rosa | TN.com.ar | Todo Noticias


cáncer mamario que se diseminó al pulmón y la cadera en 2007, pero ha tenido logros con la quimio oral con la píldora Xeloda en los últimos tres años. ...
A Pink-Ribbon Race, Years Long | HeraldTribune.com


Pat Strassner, 61, of Severna Park, Md., had breast cancer that spread to her lung and hip in 2007, but she has had success with a chemo pill called Xeloda for the past three years. The drug has side effects, including drying out the skin on her hands and ...
Agendia Planning to File IPO in 2011 | GenomeWeb Daily News | DxPGx | GenomeWeb


that may yield such precise response profiles to therapies such as tamoxifen, Xeloda (capecitabine), Taxotere (doxetacel), and Herceptin (trastuzumab). "So we take it step by step: First, who to treat … then we go to specifics: which hormonal ...
Genentech Provides Update on FDA Application for T-DM1 - MarketWatch

BioWorld Online
The EMILIA study compares T-DM1 to lapatinib in combination with capecitabine in people with advanced HER2-positive breast cancer whose disease has worsened after receiving initial treatment. About T-DM1 T-DM1 is an antibody-drug conjugate (ADC), also known as an armed antibody, being ...
Ways in which fingerprints can fade - Pasadena Star-News


As reported by the "Annals of Oncology," the chemotherapy drug he was taking - capecitabine - had caused swelling and peeling of his palms and soles. Released when officials decided he was no security risk, "Mr. S." explained he had not noticed his condition before ...
Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report


He received 3 cycles of neoadjuvant chemotherapy consisting of trastuzumab, oxaliplatin, docetaxel and capecitabine without severe toxicities except grade 2 diarrhea near the completion of cycle 3 requiring discontinuation of capecitabine. Afterwards, he received total gastrectomy with extended D2 ...
News - Pegylated Liposomal Doxorubicin May Be a First-Line Alternative to Capecitabine in Metastatic Breast Cancer: Presented at ASCO


CHICAGO -- June 6, 2010 -- The use of pegylated liposomes in the delivery of doxorubicin is similarly effective as capecitabine (CAP) in the first-line chemotherapy of metastatic breast cancer, and is better tolerated, thus presenting another treatment option for this patient population, ...
Breast cancer drug rejected by NICE | Health Insurance magazine


Lapatinib (known as Tyberb) in combination with another drug, capecitabine, is prescribed for women who have advanced breast cancer of a particular type known as HER2-positive breast cancer. NICE has ruled that it should only be used on the NHS in ...
Arch Neurol -- Sign In Page


He had metastatic colorectal carcinoma and had been receiving antineoplastic therapy with 2500 mg/m 2 of capecitabine for 2 weeks, followed by 1 week of ...
Triple Regimen Plus Radiation Effective for Esophageal Cancer - Preoperative oxaliplatin, docetaxel and capecitabine plus radiation found effective, relatively safe - ModernMedicine


WEDNESDAY, March 31 (HealthDay News) -- Chemotherapy with oxaliplatin, docetaxel and capecitabine plus radiation therapy before surgery is effective and relatively safe in patients with localized operable esophageal cancer, according to a study published online March 29 in ...
Looking for a Xeloda lawyer in District of Columbia? Get in touch with one of our Xeloda lawyers in District of Columbia now.

Need A Xeloda Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for a Xeloda lawyer in District of Columbia? Get in touch with one of our Xeloda lawyers in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Xeloda Case - Submit Your Information Below

Do you need legal assistance with your Xeloda case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Xeloda Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.